MISSISSAUGA, ON, Feb. 5 /CNW/ - Vasogen Inc. (NASDAQ:VSGN; TSX:VAS), a biotechnology Company focused on the research and commercial development of technologies targeting the chronic inflammation underlying cardiovascular and neurological disease, today announced that Chris Waddick, President and CEO, will present a Company Overview at BIO CEO & Investor Conference at the Waldorf Astoria, New York City, at 11:00 a.m. (ET) on Tuesday, February 12, 2008. The presentation will be webcast live at www.vasogen.com and a replay will also be accessible at www.vasogen.com.
